Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-07-000116
Filing Date
2007-10-02
Accepted
2007-10-02 16:59:45
Documents
1
Period of Report
2007-10-01

Document Format Files

Seq Description Document Type Size
1 aselage_form4100107ex.html 4  
1 aselage_form4100107ex.xml 4 22169
  Complete submission text file 0001048477-07-000116.txt   23861
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
ASELAGE STEVE (Reporting) CIK: 0001221599 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 071150551